Skip to main content

Day: January 11, 2024

Following a year at #1, Publicis Groupe kicks off 2024 with the One-to-One Wishes, powered by AI

Following a year at #1, Publicis kicks off 2024 with the One-to-One Wishes, powered by AI Groupe creates 100,000 personal ‘thank you’ films for every member of its team Paris – January 11, 2024 – After a year where Publicis achieved a lot of firsts – first on organic growth, first on all financial KPIs, first on new business, first on ESG, to become first in the industry in terms of market value – as always, we wanted to put our people first, and thank them one by one, for helping us to secure the #1 spot in 2023.  So we are kicking off 2024 not with one New Year’s Wish film, but 100,000 of them. One for every member of the Publicis team. In a first of its kind experiment in pushing the boundaries of AI video, storytelling and personalization at scale, Arthur’s usual New Year’s message to the group takes an unusual turn when he’s...

Continue reading

Hesai Group Announces Certain Preliminary Fourth Quarter and Full Year 2023 Revenues and Lidar Shipments Figures

Expects 4Q2023 and FY2023 net revenues to exceed the top of the guidance range of US$76 million and US$250 million, respectively Expects FY2023 total lidar shipments to exceed the guidance of 220,000 units and ADAS lidar shipments for FY2023 to exceed the target of 200,000 unitsSHANGHAI, China, Jan. 11, 2024 (GLOBE NEWSWIRE) — Hesai Group (“Hesai,” “Hesai Technology” or the “Company”) (NASDAQ: HSAI), the global leader in three-dimensional light detection and ranging (lidar) solutions, today announced certain preliminary, unaudited financial and operating results for the fourth quarter and full year 2023. These results are unaudited, subject to the completion of the Company’s year-end financial reporting processes, reviews, audit, and potential adjustments that might result therefrom.For the fourth quarter of 2023, the Company...

Continue reading

ApartmentLove Completes Development of Vacation Rental Platform as User Growth and KPIs Outperform

TORONTO, Jan. 11, 2024 (GLOBE NEWSWIRE) — ApartmentLove Inc. (CSE: APLV) (“ApartmentLove” or the “Company”), a leading provider of online home, apartment, and vacation rental marketing services to property managers, owners, renters, and vacationers from around the world is pleased to announce the successful completion of its global Short-Term Vacation Rental (“STVR”) platform, www.ownerdirect.com. “We have successfully completed all scheduled website development efforts in favor of OwnerDirect.com,” said Ken Lang – the Company’s Chief Technology Officer. Adding, “Overhauling every aspect of the application, we have successfully turned a dated legacy system into a beautiful, scalable, and proven effective global solution. Integrating with Google Hotels to display our listings on the first page of search results and with numerous...

Continue reading

Checkpoint Therapeutics to Participate in the B. Riley Securities 4th Annual Oncology Conference

WALTHAM, Mass., Jan. 11, 2024 (GLOBE NEWSWIRE) — Checkpoint Therapeutics, Inc. (“Checkpoint”) (Nasdaq: CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that James Oliviero, President and Chief Executive Officer, will participate in a fireside chat at the B. Riley Securities 4th Annual Oncology Conference, taking place on Thursday, January 18, 2024, at 4:00 p.m. EST. To access this event, please RSVP to your B. Riley Securities sales representative. A replay of Checkpoint’s fireside chat will be available on this link after the meeting. About Checkpoint Therapeutics Checkpoint Therapeutics, Inc. is a clinical-stage immunotherapy and targeted oncology company focused on the acquisition, development and commercialization of novel treatments for patients with solid tumor cancers. Checkpoint is evaluating...

Continue reading

Notifiable transaction

Hexagon Purus ASA (the “Company”) has received the attached notification form concerning the purchase of bonds in the Company by Hexagon Composites ASA, a closely associated enterprise of Jon Erik Engeset, who is a member of the Company’s board of directors. Please refer to the attached form for further information. This information is subject to the disclosure requirements pursuant to Section 5-12 the Norwegian Securities Trading ActAttachmentKRT-1500 form_11 January 2024

Continue reading

Verisk Publishes 2023 Task Force on Climate-Related Financial Disclosures (TCFD) Report

JERSEY CITY, N.J., Jan. 11, 2024 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK), a leading global data analytics and technology provider, has published its first formal report prepared in accordance with the framework recommended by the Task Force on Climate-related Financial Disclosures (TCFD). While the company regularly discloses information on its climate strategy, the report incorporates analyses of physical risk, transition risk and carbon pricing for the first time. “As a strategic partner to the global insurance industry, analyzing risks is one of the key components that drives our overall strategy and investments aimed at supporting our clients and building resilience for individuals, businesses and communities,” said Lee Shavel, Verisk president and CEO. “That same theme underlies our TCFD report. This report is more than an...

Continue reading

Avenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

MIAMI, Jan. 11, 2024 (GLOBE NEWSWIRE) — Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the treatment of neurologic diseases, today announced that Alexandra MacLean, M.D., Chief Executive Officer, will present a corporate update at the Sidoti January Micro-Cap Investor Conference on Thursday, January 18, 2024 at 10:00 a.m. EST. A webcast and subsequent archived replay of the company presentation will be available on the Events page of Avenue’s website: https://avenuetx.com/ for approximately 90 days following the meeting. Avenue Therapeutics will also host virtual one-on-one meetings with investors on Wednesday, January 17 and Thursday, January 18. To register for the conference and schedule a one-on-one meeting,...

Continue reading

Cellebrite Announces Participation in the 26th Annual Needham Growth Conference

TYSONS CORNER, Va. and PETAH TIKVA, Israel, Jan. 11, 2024 (GLOBE NEWSWIRE) — Cellebrite (NASDAQ: CLBT), a global leader in premier Digital Investigative solutions for the public and private sectors, today announced the Company will participate in the upcoming 26th Annual Needham Growth Conference. Relevant details include:Date: January 18, 2024Conference: Needham & Co. 26th Annual Growth ConferencePresentation Time: 1:30 p.m. ETFormat Fireside ChatEvent URL: https://investors.cellebrite.com/events/event-details/needham-company-26th-annual-growth-conferenceCellebrite Executives: Dana Gerner, chief financial officer  Andrew Kramer, vice president, investor relationsAbout Cellebrite Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice and preserve...

Continue reading

Spectral AI Begins Enrollment in Pivotal Study to Validate DeepView AI® for Burn Injuries

DALLAS, Jan. 11, 2024 (GLOBE NEWSWIRE) — Spectral AI, Inc. (NASD:MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in clinical wound care, announces the enrollment of the first patient in the pivotal study to validate DeepView AI® using its proprietary imaging technology for burn size and healing assessment. This pivotal study is expected to be the final clinical trial before seeking FDA marketing authorization for the burn indication in 2025 and will be conducted in burn centers and emergency departments across the US, enrolling both adults and pediatric patients. Niko Pagoulatos, Ph.D., Chief Operating Officer of the Company stated: “We believe this study will further demonstrate the truly innovative and versatile nature...

Continue reading

Enviri Corporation Announces Timing Of Fourth Quarter And Full Year 2023 Results And Conference Call

PHILADELPHIA, Jan. 11, 2024 (GLOBE NEWSWIRE) — Enviri Corporation (NYSE: NVRI) today announced that it will issue its fourth quarter and full year 2023 earnings results on Thursday, February 29, 2024 prior to NYSE market open. The Company will also host its quarterly conference call and webcast that morning beginning at 9:00 a.m. ET. Those who wish to listen to the conference call webcast should visit the Investor Relations section of the Company’s website at www.enviri.com. The live call also can be accessed using the below dial-in details. Please ask to join the Enviri Corporation call. Listeners are advised to dial in approximately ten minutes prior to the call. If you are unable to listen to the live call, the webcast will be archived on the Company’s website. Conference Call Details for Investors and Financial Analysts Date:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.